|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
The Hungarian national trademark system is more than 100 years old. Current trademark law has been in force since July 1997, quite some time after the political changes of 1990. This was primarily because trademark law was considered fairly modern when it was instituted in 1969, as it was uniquely market-oriented even at the time of the socialist regime and fulfilled its role even up to the early 1990s.
As Hungary prepares to join the EU, its legislation, including that dedicated to IP protection, is undergoing continuous adjustment. This explains the frequent amendments to the current trademark law. A final major package of amendments is expected to come out during the next year when the transitional rules regarding the extension of the community trademark system to Hungary will come to fruition.
These amendments will extend the territorial limits of exhaustion of rights from the current national limits to the whole European Union. It is not yet known whether the trademark opposition system will then be introduced or if the current system will remain in force, wherein the validity of national trademarks can only be questioned in a cancellation proceeding initiated against the trademark concerned.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EMBALLAGE 2008. World Packaging Exhibition
16-21 November 2008, Paris-Nord Villepinte - France
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
